Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where E. Dussaix is active.

Publication


Featured researches published by E. Dussaix.


Clinical Transplantation | 2005

Could post-liver transplantation course be helpful for the diagnosis of so called cryptogenic cirrhosis?

J.-C. Duclos-Vallee; Funda Yilmaz; Catherine Johanet; A.-M. Roque-Afonso; Michelle Gigou; Catherine Trichet; Cyrille Feray; Eric Ballot; E. Dussaix; D. Castaing; H. Bismuth; D. Samuel; C. Guettier

Abstract:  Cryptogenic cirrhosis (CC) is diagnosed in 5–30% of cirrhotic patients overall and 7% of patients who undergo liver transplantation for cirrhosis. In our series of patients transplanted for CC, pre‐transplant clinical and histological data and the post‐transplant course were reexamined in an attempt to identify the aetiology. Among the 881 patients transplanted in our centre between 1987 and 2000, 28 patients with a median age of 46 yr (range: 18–69) at transplantation were initially classified as having CC. Two patients were excluded because of intense ischaemic lesions caused by chemoembolization prevented histological analysis of the native liver (n = 1) and because of cryptic HBV infection (n = 1). Among the remaining 26 patients, four groups were individualized: (i) patients with chronic inflammatory liver disease with autoimmune features (n = 14, 54%); (ii) patients with features suggestive of non‐alcoholic fatty liver disease (n = 3, 11.5%); (iii); patients with incomplete septal cirrhosis (ISC) and vascular liver disease (n = 3), and (iv) patients with unresolved CC (n = 6, 23%). In the autoimmune liver disease group, the median International Autoimmune Hepatitis score was 12.5 (range: 11–19) after reevaluation and review of the post‐transplantation course was helpful to confirm the diagnosis with the occurrence of active graft hepatitis in nine patients, with autoantibodies in five patients. The vascular group was characterized by lesions of obliterative portal venopathy and ISC in all native livers. Diagnosis of NAFLD was based on the clinical background of obesity and/or type 2 diabetes and the presence of steatosis or steatohepatitis in native livers and graft biopsies. A definite aetiological diagnosis can be achieved in the majority of patients initially diagnosed with CC. Autoimmune liver disease emerged as the main aetiology (14 of 26 patients, 54%) and frequently recurred on the grafted liver (nine cases). In all cases a precise diagnosis is obviously of practical interest for better management of post‐transplant survey and treatment.


Journal of Hepatology | 2005

Hepatitis C virus viral recurrence and liver mitochondrial damage after liver transplantation in HIV–HCV co-infected patients

J.-C. Duclos-Vallee; D. Vittecoq; Elina Teicher; Cyrille Feray; A.-M. Roque-Afonso; Anne Lombès; Claude Jardel; Michelle Gigou; E. Dussaix; Mylène Sebagh; C. Guettier; Daniel Azoulay; R. Adam; Philippe Ichaï; Faouzi Saliba; Bruno Roche; D. Castaing; H. Bismuth; D. Samuel


Journal of Hepatology | 2007

[175] SPECIFIC ANTI-HCV IMMUNE RESPONSES AFTER LIVER TRANSPLANTATION IN HIV/HCV CO-INFECTED PATIENTS

Assia Samri; A.-M. Roque-Afonso; O. Beran; C. Feray; E. Dussaix; D. Samuel; Brigitte Autran; J.-C. Duclos-Vallee


Journal of Hepatology | 2004

124 HCV viral recurrence and liver mitochondrial damage after liver transplantation (LT) in HIV-HCV coinfected patients

J.-C. Duclos-Vallee; D. Vittecoq; Elina Teicher; C. Feray; A.-M. Roque-Afonso; Anne Lombès; Claude Jardel; M. Gigou; E. Dussaix; C. Guettier; M. Sebagh; Daniel Azoulay; R. Adam; P. Ichai; Faouzi Saliba; B. Roche; D. Castaing; D. Samuel


Journal of Hepatology | 2004

160 Severe primary HHV8 infection following transplantation with anti-HHV8-positive liver grafts

A.-M. Roque-Afonso; Anne-Geneviève Marcelin; E. Kimmoun; Monika Hurtova; Micheline Tulliez; M. Sebagh; Nicolas Dupin; C. Guettier; D. Samuel; Vincent Calvez; E. Dussaix


Journal of Hepatology | 2004

265 HBV recurrence associated with HCC recurrence after liver transplantation: Role of HBV production from tumoral cells

B. Roche; M. Gigou; A.-M. Roque-Afonso; M. Sebagh; C. Guettier; E. Dussaix; D. Samuel


Journal of Hepatology | 2004

473 Compartimentalization of hepatitis C virus and response to therapy

G. Diliberto; Delphine Ducoulombier; A.-M. Roque-Afonso; M. Gigou; E. Dussaix; C. Guettier; D. Samuel; C. Feray


Journal of Hepatology | 2003

Indeterminate fulminant hepatitis: Clinico-pathological, immunological and virological reevaluation of the pre and post transplantation period of 31 cases transplanted since 1987

E. Kimmoun; A.-M. Roque-Afonso; Catherine Johanet; P. Ichai; Faouzi Saliba; B. Roche; R. Adam; Daniel Azoulay; D. Castaing; Funda Yilmaz; M. Gigou; C. Guettier; E. Dussaix; H. Bismuth; D. Samuel; J.-C. Duclos-Vallee


Journal of Hepatology | 2003

Persistence in blood mononuclear cells of hepatitis C virus genotypes undetectable in plasma: Role of dual viral tropism and repeated exposure

Anne-Marie Roque-Afonso; Delphine Ducoulombier; Rachid Kara; M. Gigou; X. Bing; E. Gault; E. Dussaix; C. Feray


Journal of Hepatology | 2003

Pilot study of treatment with pegylated interferon and ribavirin in liver transplant recipients with hepatitis C infection

B. Roche; A.-M. Roque-Afonso; M. Sebagh; C. Feray; C. Guettier; E. Dussaix; D. Castaing; D. Samuel

Collaboration


Dive into the E. Dussaix's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

B. Roche

Université Paris-Saclay

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

M. Sebagh

University of Paris-Sud

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge